NASDAQ:MITA Coliseum Acquisition (MITA) Stock Price, News & Analysis → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free MITA Stock Alerts $10.82 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$10.82▼$10.8250-Day Range$10.72▼$11.4452-Week Range$10.26▼$11.81Volume76 shsAverage Volume929 shsMarket Capitalization$71.74 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Coliseum Acquisition alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Coliseum Acquisition Stock (NASDAQ:MITA)Coliseum Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Coliseum Acquisition Corp. was incorporated in 2021 and is based in New York, New York.Read More MITA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MITA Stock News HeadlinesOctober 18, 2023 | money.usnews.comColiseum Acquisition Corp - Ordinary Shares - Class ASeptember 26, 2023 | finance.yahoo.comColiseum Acquisition Corp. Announces Fourth Extension of Deadline to Complete Initial Business CombinationApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!June 15, 2023 | finance.yahoo.comColiseum Acquisition Corp. Announces Cash Contribution to Trust Account in Connection with Proposed Extension Amendment, Planned Adjournment of Shareholders’ Meeting to Thursday, June 22, 2023, and Extension of Redemption Request DeadlineMay 31, 2023 | wsj.comColiseum Acquisition Corp. Cl AMarch 18, 2023 | theguardian.comDismay as Oldham Coliseum confirms final closure at end of MarchDecember 12, 2022 | finance.yahoo.comWith 47% stake, Coliseum Acquisition Corp. (NASDAQ:MITA) seems to have captured institutional investors' interestSeptember 25, 2022 | nypost.comChris Bassitt excited to show Mets ‘some fun things’ at Oakland ColiseumApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!August 19, 2022 | uk.finance.yahoo.comColiseum Acquisition Corp. (MITA)August 19, 2022 | investing.comColiseum Acquisition Corp (MITA)July 4, 2022 | finance.yahoo.comWhat Type Of Shareholders Own The Most Number of Coliseum Acquisition Corp. (NASDAQ:MITA) Shares?January 18, 2022 | finance.yahoo.comEllsworth Advisors, LLC Buys Coliseum Acquisition Corp, Activision Blizzard Inc, Fiserv Inc,December 30, 2021 | thestreet.comNGCA and ATHN Deals Approved as SPACs Quietly Move Toward 2022See More Headlines Receive MITA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Coliseum Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:MITA CUSIPN/A CIK1847440 Webwww.coliseumacq.com Phone212-600-5763FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.10 million Net MarginsN/A Pretax MarginN/A Return on Equity-40.56% Return on Assets1.74% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.36 per share Price / Cash Flow30.15 Book Value($0.69) per share Price / Book-15.68Miscellaneous Outstanding Shares6,630,000Free Float4,817,000Market Cap$71.74 million OptionableNot Optionable Beta0.03 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Charles E. Wert (Age 80)CEO & Director Ms. Oanh Do Ngoc Truong (Age 35)Chief Financial Officer Key CompetitorsMetal Sky Star AcquisitionNASDAQ:MSSAFour Leaf AcquisitionNASDAQ:FORLFortune Rise AcquisitionNASDAQ:FRLAClean Energy Special SituationsNASDAQ:SWSSOCA AcquisitionNASDAQ:OCAXView All CompetitorsInstitutional OwnershipKarpus Management Inc.Bought 240,000 shares on 2/13/2024Ownership: 2.492%Cowen AND Company LLCSold 100,845 shares on 2/8/2024Ownership: 0.934%Robinson Capital Management LLCBought 36,580 shares on 2/8/2024Ownership: 0.380%View All Institutional Transactions MITA Stock Analysis - Frequently Asked Questions How have MITA shares performed in 2024? Coliseum Acquisition's stock was trading at $10.66 at the beginning of the year. Since then, MITA stock has increased by 1.5% and is now trading at $10.82. View the best growth stocks for 2024 here. Are investors shorting Coliseum Acquisition? Coliseum Acquisition saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 700 shares, a decrease of 41.7% from the March 31st total of 1,200 shares. Based on an average trading volume of 1,700 shares, the short-interest ratio is currently 0.4 days. Approximately 0.0% of the shares of the company are sold short. View Coliseum Acquisition's Short Interest. What ETF holds Coliseum Acquisition's stock? Robinson Alternative Yield Pre-Merger SPAC ETF holds 28,127 shares of MITA stock, representing 1.99% of its portfolio. How do I buy shares of Coliseum Acquisition? Shares of MITA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MITA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsI’m afraid WWIII is a very real possibility Porter & CompanyThe AI stock to buy right nowStockEarningsThe Next Nvidia?InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coliseum Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
